ADAM: Disintegrin and Metalloproteinase Domain-containing Protein

Target Name: Disintegrin and Metalloproteinase domain-containing protein (ADAM) (nospecified subtype)

NCBI ID: P45384

Disintegrin and Metalloproteinase domain-containing protein (ADAM) (nospecified subtype)

Other Name(s): ADAM

ADAM: Disintegrin and Metalloproteinase Domain-containing Protein

Disintegrin and Metalloproteinase domain-containing protein (ADAM) is a protein that plays a crucial role in many cellular processes. It is a transmembrane protein that is involved in several different signaling pathways, including the TGF-β pathway and the FGF signaling pathway.

ADAM is a protein that is expressed in many different tissues, including the brain, heart, and liver. It is involved in the regulation of cell growth, differentiation, and survival. It is also involved in the regulation of cell-cell and cell-tissue interactions, as well as in the regulation of the cytoskeleton.

One of the unique features of ADAM is its ability to regulate the activity of other proteins. It does this by interacting with the protein known as Metalloproteinase (MP), which is a protein that is involved in the regulation of many different cellular processes.

ADAM and MP have a domain-containing interaction, which allows them to work together to regulate the activity of other proteins. This interaction between ADAM and MP is critical for the regulation of cell growth, differentiation, and survival.

One of the functions of ADAM is to regulate the activity of Metalloproteinase (MP) enzymes. MP is a protein that is involved in the regulation of many different cellular processes, including cell growth, differentiation, and apoptosis.

ADAM can interact with MP to prevent the activity of MP enzymes. This interaction between ADAM and MP helps to maintain the stability of the cytoskeleton and allows cells to maintain proper posture and structure.

Another function of ADAM is to regulate the activity of the protein known as Integrin. Integrin is a protein that is involved in cell-cell and cell-tissue interactions. It is essential for the proper functioning of cells, and it is involved in many different cellular processes, including cell growth, migration, and invasion.

ADAM can interact with Integrin to prevent its activity. This interaction between ADAM and Integrin helps to maintain the stability of the cytoskeleton and allows cells to maintain proper posture and structure.

In conclusion, Disintegrin and Metalloproteinase domain-containing protein (ADAM) is a protein that plays a crucial role in many cellular processes. It is involved in the regulation of cell growth, differentiation, and survival, as well as in the regulation of cell-cell and cell-tissue interactions.

ADAM has been identified as a potential drug target and a biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. Its ability to regulate the activity of other proteins makes it an attractive target for drug development.

Furthermore, the study of ADAM has also provided new insights into the regulation of cellular processes, including cell-cell and cell-tissue interactions. The interaction between ADAM and MP and Integrin is a complex process that is essential for the proper functioning of cells.

Overall, Disintegrin and Metalloproteinase domain-containing protein (ADAM) is a protein that has important roles in many cellular processes. Its ability to regulate the activity of other proteins makes it a potential drug target and a biomarker for several diseases. Further research is needed to fully understand its functions and the mechanisms that regulate its activity.

Protein Name: Disintegrin And Metalloproteinase Domain-containing Protein (ADAM) (nospecified Subtype)

The "Disintegrin and Metalloproteinase domain-containing protein (ADAM) (nospecified subtype) Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Disintegrin and Metalloproteinase domain-containing protein (ADAM) (nospecified subtype) comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets